InNexus Biotechnology (InNexus Biotechnology) YoY EBITDA Growth : 88.89% (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. InNexus Biotechnology's YoY EBITDA Growth for the quarter that ended in Mar. 2011 was 88.89%.

InNexus Biotechnology's EBITDA per Share for the three months ended in Mar. 2011 was $-0.00.

InNexus Biotechnology YoY EBITDA Growth Historical Data

The historical data trend for InNexus Biotechnology's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology YoY EBITDA Growth Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

YoY EBITDA Growth

Get a 7-Day Free Trial

-11.25

-31.46

20.51

20.43

60.81

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
YoY EBITDA Growth	Get a 7-Day Free Trial															52.63	54.55	80.00	66.67	88.89

InNexus Biotechnology YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

InNexus Biotechnology's YoY EBITDA Growth for the fiscal year that ended in Jun. 2010 is calculated as:

	YoY EBITDA Growth (A: Jun. 2010 )
=	(EBITDA per Share (A: Jun. 2010 )	-	EBITDA per Share (A: Jun. 2009 ))	/	\| EBITDA per Share (A: Jun. 2009 ) \|
=	(-0.029	-	-0.074)	/	\| -0.074 \|
=	60.81 %

InNexus Biotechnology's YoY EBITDA Growth for the quarter that ended in Mar. 2011 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2011 )
=	(EBITDA per Share (Q: Mar. 2011 )	-	EBITDA per Share (Q: Mar. 2010 ))	/	\| EBITDA per Share (Q: Mar. 2010 )) \|
=	(-0.001	-	-0.009)	/	\| -0.009 \|
=	88.89 %

InNexus Biotechnology YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines